Advertisement

Vasopressine et analogues

  • A. Delmas
  • F. Garnier
  • C. Martin
Part of the Le point sur⋯ book series (POINT)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Landry DW, Levin HR, Gallant EM et al. (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25: 1279–82PubMedGoogle Scholar
  2. 2.
    Okamura T, Toda M, Ayajiki K, Toda N (1997) Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries. J Vasc Res 34: 464–72PubMedGoogle Scholar
  3. 3.
    Landry DW, Levin H, Gallant E et al. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95: 1122–5PubMedGoogle Scholar
  4. 4.
    Gold J, Cullinane S, Chen J et al. (2000) Vasopressin in the treatment of milrinone induced hypotension in severe heart failure. Am J Cardiol 85: 506–88, A11PubMedGoogle Scholar
  5. 5.
    Laszlo FA, Laszlo F Jr, De Wield D (1991) Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 43: 73–108PubMedGoogle Scholar
  6. 6.
    Forrest P (2001) Vasopressin and shock. Anaesth Intensive Care 29(5): 463–72PubMedGoogle Scholar
  7. 7.
    Krismer AC, Wenzel V, Mayr VD et al. (2001) Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives. Curr opin in Crit Care 7: 157–69Google Scholar
  8. 8.
    Holmes CL, Patel BM, Russell JA (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120,3: 989–99CrossRefPubMedGoogle Scholar
  9. 9.
    Malay MB, Ashton RC Jr, Landry DW, Townsend RN (1999) Low dose of vasopressin in the treatment of vasodilatory septic shock. J Trauma 47: 699–703PubMedGoogle Scholar
  10. 10.
    Argenziano M, Chen JM, Choudhri AF et al. (1998) Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. Thorac Cardiovasc Surg 116: 973–80Google Scholar
  11. 11.
    Argenziano M, Choudhri AF, Oz MC et al. (1997) A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 96: 286–90Google Scholar
  12. 12.
    Argenziano M, Chen JM, Cullinane S et al. (1999) Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Transplant 18: 814–7Google Scholar
  13. 13.
    Morales DL, Gregg D, Helman DN et al. (2000) Arginine vasopressin in the treatment of 50 patients with post cardiotomy vasodilatory shock. Ann Thorac Surg 69: 102–6CrossRefPubMedGoogle Scholar
  14. 14.
    Chen JM, Cullinane S, Spanier TB et al. (1999) Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 100: II-244–6Google Scholar
  15. 15.
    Tsuneyoshi I, Yamada H, Kakihana Y et al. (2001) 3rd Hemodynamic and metabolic effects of low dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29,3: 487–93PubMedGoogle Scholar
  16. 16.
    Holmes CL, Walley KR, Chittock DR et al. (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27: 1416–21CrossRefPubMedGoogle Scholar
  17. 17.
    Dünser M, Luckner G, Mayr A et al. (2000) Hemodynamic changes during continuous infusion of vasopressin in critically ill patients with severe MODS. Intensive Care Med [résumé] 26,3: S219Google Scholar
  18. 18.
    Lauzier F, Berard D, Lamarre P et al. (2002) Vasopressine contre noradrenaline dans la prise en charge initiale du choc septique: analyse intermédiaire d’ une étude clinique randomisée. Reanim Urg [résumé] 10(Suppl. 1): 53s–4sGoogle Scholar
  19. 19.
    Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576–82CrossRefPubMedGoogle Scholar
  20. 20.
    Nicolet-Barousse L, Sharshar T, Paillard M, Blanchard A (2001) La vasopressine: une hormone aux multiples fonctions. Médecine thérapeutique-Endocrinologie 7: 757–64Google Scholar
  21. 21.
    Prengel AW, Lindner KH, Ensinger H, Grunert A (1992) Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med 20: 609–14PubMedGoogle Scholar
  22. 22.
    Lindner KH, Strohmenger HU, Prengel AW et al. (1992) Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model. Crit Care Med 20: 1020–6PubMedGoogle Scholar
  23. 23.
    Schultz CH, Rivers EP, Feldcamps CS et al. (1993) A characterization of hypothalamicpituitaryadrenal axis function during and after human cardiac arrest. Crit Care Med 21: 1339–47PubMedGoogle Scholar
  24. 24.
    Lindner KH, Strohmenger HU, Ensinger H et al. (1992) Stress hormone response during and after CPR. Anesthesiology 77: 662–8PubMedGoogle Scholar
  25. 25.
    Lindner KH, Haak T, Keller A et al. (1996) Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 75: 145–50PubMedGoogle Scholar
  26. 26.
    Schwartz J, Reid IA (1983) Role of vasopressin in blood pressure regulation in conscious water-deprived dogs. Am J Physiol 244: R74–7PubMedGoogle Scholar
  27. 27.
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1658–62Google Scholar
  28. 28.
    Ruokonen G, Takala J, Kari Y, Alhava E (1991) Septic shock and multi organ failure. Crit Care Med 19: 1146–51PubMedGoogle Scholar
  29. 29.
    Parrillo JE, Parker MM, Natanson C et al. (1990) Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227–42PubMedGoogle Scholar
  30. 30.
    Martin C, Eon B, Saux P et al. (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282–5Google Scholar
  31. 31.
    Fukuoka T, Nishimura N, Imanaka H et al. (1989) Effects of norepinephrine on renal function in septic patients with normal or elevated serum lactate levels. Crit Care Med 17: 1104–7PubMedGoogle Scholar
  32. 32.
    Martin C, Papazian L, Perrin G et al. (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103: 1826–31PubMedGoogle Scholar
  33. 33.
    Ruokonen E, Takala J, Kari A et al. (1993) Regional blood flow and oxygen transport in septic shock. Crit Care Med 21: 1296–303PubMedGoogle Scholar
  34. 34.
    Van Haren FMP, Rozendaal FW, Van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124, 2256–60PubMedGoogle Scholar
  35. 35.
    Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 107, 2313–9PubMedGoogle Scholar
  36. 36.
    Bracco D et al. (2001) ESICM, 14th Annual Congress. Abstract no 15.Google Scholar
  37. 37.
    Sladen RN et al. (2002) ASA meeting. Anesthesiology 96, A349Google Scholar
  38. 38.
    O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359: 1209–10PubMedGoogle Scholar
  39. 39.
    Léone M, Albanese J, Delmas A et al. (2004) Terlipressine in catecholamine-resistant septic shock patients. Shock 22, 314–9PubMedGoogle Scholar
  40. 40.
    Morelli A, Rocco M, Conti G et al. (2004) Effects of terlipressin on gastric mucosa in catecholamine-dependent septic shock. Intensive Care Med 30, 597–604CrossRefPubMedGoogle Scholar
  41. 41.
    Westphal M Stubbe H, Sielenkämper AW et al. (2003) Terlipressin response in healthy and endotoxinemic sheep: impact on cardiopulonary performance and global oxygen. Intensive Care Med 29, 301–8PubMedGoogle Scholar
  42. 42.
    Rodriguez-Numez A, Fernandez-Sanmartin M, Martinon-Torres F et al. (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30, 477–80Google Scholar

Copyright information

© Springer-Verlag France 2005

Authors and Affiliations

  • A. Delmas
  • F. Garnier
  • C. Martin

There are no affiliations available

Personalised recommendations